Polyphyllin VII achieves the treatment of osteoarthritis by reducing TNF-α, IL-6, and IL-1β levels in knee joint fluid and inhibiting IL-1β, MMP9, and ADAMTS-5. Here, IL1B is linked to osteoarthritis.